국소 약물 포장 시장 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2025-2034년)

The Global Topical Drugs Packaging Market was valued at USD 32.1 billion in 2024 and is estimated to grow at a CAGR of 7.9% to reach USD 67.5 billion by 2034. Rising skin conditions and growing direct-to-consumer sales channels, particularly online, are among the primary growth drivers. The boom in e-commerce has opened new pathways for pharmaceutical companies, especially those offering topical solutions, to reach broader audiences directly.

With skin conditions like acne, eczema, and psoriasis becoming increasingly prevalent, pharmaceutical firms are focusing more on accessible and effective topical treatments, which in turn boosts demand for safe and innovative packaging. Digital tech adoption in packaging-such as QR verification, tamper-proof seals, and track-and-trace capabilities-is gaining traction in high-value and OTC dermatology products. Sustainability continues to reshape packaging choices. Market players are integrating eco-conscious solutions, including recyclable plastics, refill systems, and biodegradable films, reflecting shifting consumer and regulatory expectations in the pharmaceutical sector. These sustainable packaging innovations are not only helping reduce environmental impact but also enhancing brand reputation and consumer trust. Companies are increasingly investing in the development of lightweight, resource-efficient materials that minimize waste throughout the product lifecycle. The use of mono-material structures for easier recyclability, along with reduced carbon footprint packaging processes, is becoming more common across the industry. Additionally, there's a growing push for closed-loop systems, where used packaging is collected and reprocessed into new products. Such initiatives align with global sustainability goals while meeting the rising demand for ethical and environmentally responsible healthcare solutions.

In 2024, the rigid formats segment held a 42.4% share. Bottles, glass containers, and jars are widely used for premium and prescription skin treatments as they offer protection, preserve product quality, and support storage stability. These containers are particularly favored for their ability to handle viscous formulations and maintain structural integrity for sensitive applications.

The liquid product segment is forecasted to grow at a CAGR of 7.9% from 2025 to 2034. Liquids, including antiseptics and medicated sprays, demand precise, secure packaging that prevents spills and contamination while supporting active ingredient preservation and dosing accuracy.

North America Topical Drugs Packaging Market held 37.6% share in 2024 and is set to grow at a CAGR of 6.9% throughout 2025-2034. Strong pharmaceutical infrastructure, a preference for OTC medication, and growing self-care habits are advancing packaging innovation in this region. Increased reliance on e-commerce and user-friendly packaging that ensures safety and compliance continues to shape the demand landscape in the US and Canada.

Leading companies in Topical Drugs Packaging Market include West Pharmaceutical Services, Schott, AptarGroup, Gerresheimer, and Amcor. Topical drug packaging companies are investing heavily in sustainable materials, digital security, and advanced dispensing systems to cater to the evolving needs of both consumers and pharmaceutical clients. Brands are innovating with refillable containers, biodegradable packaging films, and low-carbon manufacturing to align with environmental regulations and consumer preferences. Product differentiation is being enhanced through tamper-proof closures, ergonomic design, and serialization technologies that add traceability and consumer confidence. Companies are also forming strategic partnerships with pharmaceutical manufacturers to co-develop packaging formats tailored to specialized dermatological products.

Table of Contents

Chapter 1 Methodology

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis, 2021 - 2034
• 2.2 Key market trends
  • 2.2.1 Packaging type trends
  • 2.2.2 Packaging material trends
  • 2.2.3 Product types trends
  • 2.2.4 Drug type trends
  • 2.2.5 Closure type trends
  • 2.2.6 Mode of administration trends
  • 2.2.7 Application trends
  • 2.2.8 Regional trends
• 2.3 TAM Analysis, 2025-2034 (USD Million)
• 2.4 CXO perspectives: Strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin analysis
  • 3.1.3 Cost structure
  • 3.1.4 Value addition at each stage
  • 3.1.5 Factor affecting the value chain
  • 3.1.6 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of skin diseases and dermatological disorders
    • 3.2.1.2 Growing demand for convenient and user-friendly packaging formats
    • 3.2.1.3 Expansion of over-the-counter (OTC) topical drug products
    • 3.2.1.4 Growth of e-commerce and direct-to-consumer pharmaceutical sales
    • 3.2.1.5 Innovation in unit dose and controlled-dispensing systems
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulatory compliance and approval processes
    • 3.2.2.2 Complexities in designing child-resistant yet senior-friendly packaging
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expansion into emerging markets with underserved dermatological needs.
    • 3.2.3.2 Integration of smart packaging technologies for authentication and patient engagement.
    • 3.2.3.3 Rising investment in sustainable and biodegradable packaging solutions.
    • 3.2.3.4 Growth of private-label topical product lines by retail pharmacy chains.
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Technology and Innovation landscape
  • 3.7.1 Current technological trends
  • 3.7.2 Emerging technologies
• 3.8 Price trends
  • 3.8.1 Historical price analysis (2021-2024)
  • 3.8.2 Price trend drivers
  • 3.8.3 Regional price variations
  • 3.8.4 Price Forecast (2025-2034)
• 3.9 Pricing strategies
• 3.10 Emerging business models
• 3.11 Compliance requirements
• 3.12 Sustainability measures
  • 3.12.1 Sustainable materials assessment
  • 3.12.2 Carbon footprint analysis
  • 3.12.3 Circular economy implementation
  • 3.12.4 Sustainability certifications and standards
  • 3.12.5 Sustainability ROI Analysis
• 3.13 Global consumer sentiment analysis
• 3.14 Patent analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 Latin America
    • 4.2.1.5 Middle East & Africa
• 4.3 Competitive benchmarking of key players
  • 4.3.1 Financial performance comparison
    • 4.3.1.1 Revenue
    • 4.3.1.2 Profit margin
    • 4.3.1.3 R&D
  • 4.3.2 Product portfolio comparison
    • 4.3.2.1 Product range breadth
    • 4.3.2.2 Technology
    • 4.3.2.3 Innovation
  • 4.3.3 Geographic presence comparison
    • 4.3.3.1 Global footprint analysis
    • 4.3.3.2 Service network coverage
    • 4.3.3.3 Market penetration by region
  • 4.3.4 Competitive positioning matrix
    • 4.3.4.1 Leaders
    • 4.3.4.2 Challengers
    • 4.3.4.3 Followers
    • 4.3.4.4 Niche players
  • 4.3.5 Strategic outlook matrix
• 4.4 Key developments, 2021-2024
  • 4.4.1 Mergers and acquisitions
  • 4.4.2 Partnerships and collaborations
  • 4.4.3 Technological advancements
  • 4.4.4 Expansion and investment strategies
  • 4.4.5 Sustainability initiatives
  • 4.4.6 Digital transformation initiatives
• 4.5 Emerging/ startup competitors landscape

Chapter 5 Market Estimates and Forecast, By Packaging Type, 2021 - 2034 (USD Million & Kilo Tons)

• 5.1 Key trends
• 5.2 Flexible packaging
• 5.3 Rigid packaging
• 5.4 Semi-rigid packaging

Chapter 6 Market Estimates and Forecast, By Packaging Material, 2021 - 2034 (USD Million & Kilo Tons)

• 6.1 Key trends
• 6.2 Plastic
• 6.3 Glass
• 6.4 Metal
• 6.5 Paper
• 6.6 Aluminium
• 6.7 Others

Chapter 7 Market Estimates and Forecast, By Product Types, 2021 - 2034 (USD Million & Kilo Tons)

• 7.1 Key trends
• 7.2 Bottles
• 7.3 Caps & closures
• 7.4 Inhalers
• 7.5 Tubes
• 7.6 Jars
• 7.7 Others

Chapter 8 Market Estimates and Forecast, By Drug Type, 2021 - 2034 (USD Million & Kilo Tons)

• 8.1 Key trends
• 8.2 Liquid
• 8.3 Semi-solid
• 8.4 Solid
• 8.5 Transdermal

Chapter 9 Market Estimates and Forecast, By Closure Type, 2021 - 2034 (USD Million & Kilo Tons)

• 9.1 Key trends
• 9.2 Screw cap
• 9.3 Flip-top cap
• 9.4 Pump dispenser
• 9.5 Dropper
• 9.6 Nozzle

Chapter 10 Market Estimates and Forecast, By Mode of Administration, 2021 - 2034 (USD Million & Kilo Tons)

• 10.1 Key trends
• 10.2 Ophthalmic usage
• 10.3 Nasal usage
• 10.4 Dermal usage

Chapter 11 Market Estimates and Forecast, By Application, 2021 - 2034 (USD Million & Kilo Tons)

• 11.1 Key trends
• 11.2 Dermatology
• 11.3 Ophthalmology
• 11.4 Others

Chapter 12 Market Estimates & Forecast, By Region, 2021 - 2034 (USD Million & Kilo Tons)

• 12.1 Key trends
• 12.2 North America
  • 12.2.1 U.S.
  • 12.2.2 Canada
• 12.3 Europe
  • 12.3.1 Germany
  • 12.3.2 UK
  • 12.3.3 France
  • 12.3.4 Italy
  • 12.3.5 Spain
  • 12.3.6 Netherlands
• 12.4 Asia Pacific
  • 12.4.1 China
  • 12.4.2 India
  • 12.4.3 Japan
  • 12.4.4 Australia
  • 12.4.5 South Korea
• 12.5 Latin America
  • 12.5.1 Brazil
  • 12.5.2 Mexico
  • 12.5.3 Argentina
• 12.6 MEA
  • 12.6.1 South Africa
  • 12.6.2 Saudi Arabia
  • 12.6.3 UAE

Chapter 13 Company Profiles

• 13.1 Global Key Players
  • 13.1.1 Amcor
  • 13.1.2 AptarGroup
  • 13.1.3 Gerresheimer
  • 13.1.4 Schott
  • 13.1.5 West Pharmaceutical Services
• 13.2 Regional Key Players
  • 13.2.1 North America
    • 13.2.1.1 Catalent
    • 13.2.1.2 WestRock
    • 13.2.1.3 Sonoco Products
    • 13.2.1.4 ProAmpac
    • 13.2.1.5 Silgan Holdings
  • 13.2.2 Europe
    • 13.2.2.1 Bormioli Pharma
    • 13.2.2.2 Constantia Flexibles
    • 13.2.2.3 Mondi
    • 13.2.2.4 SGD Pharma
  • 13.2.3 APAC
    • 13.2.3.1 Huhtamaki
    • 13.2.3.2 Nipro
    • 13.2.3.3 EPL Limited
• 13.3 Niche Players / Disruptors
  • 13.3.1 CCL Industries
  • 13.3.2 LOG Pharma Primary Packaging
  • 13.3.3 Nelipak